Cargando…
Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy
SIMPLE SUMMARY: Cutaneous squamous cell carcinoma (cSCC) is the second most prevalent skin cancer globally. Immunosuppression raises cSCC incidence rates, while high immunogenicity of the cutaneous tissue enables topical immunotherapy. Intriguingly, expanded applications of programmed death-1 (PD-1)...
Autores principales: | Ishitsuka, Yosuke, Hanaoka, Yuma, Tanemura, Atsushi, Fujimoto, Manabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962464/ https://www.ncbi.nlm.nih.gov/pubmed/33800195 http://dx.doi.org/10.3390/cancers13051148 |
Ejemplares similares
-
c-FOS Expression in Metastatic Basal Cell Carcinoma with Spontaneous Basosquamous Transition
por: KUROKAMI, Yu, et al.
Publicado: (2023) -
Successful High-Dose Radiation Treatment for Chemo-Resistant Oral Squamous Cell Carcinoma in a Kindler's Syndrome Patient
por: Kimura, Yuka, et al.
Publicado: (2021) -
A Rare Case of Atrophic Dermatofibroma Featuring Linear Skin Dimple
por: Takafuji, Madoka, et al.
Publicado: (2019) -
Ganglioside GD3 May Suppress the Functional Activities of Benign Skin T Cells in Cutaneous T-Cell Lymphoma
por: Kume, Miki, et al.
Publicado: (2021) -
Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma
por: Aboul-Fettouh, Nader, et al.
Publicado: (2021)